Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using gut blood flow measurements to predict feeding intolerance in critically ill adults

Official title: Study on the Predictive Value of Gastrointestinal Blood Flow for Enteral Nutrition Intolerance in Critically Ill Patients

Run by Ruijin Hospital · NCT07521111 · Data updated 2026-11-12

This study will test whether bedside ultrasound measurements of gastrointestinal blood flow can help predict which critically ill adults receiving enteral nutrition will develop feeding intolerance.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorRuijin Hospital
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedJanuary 25, 2026
Main results expectedDecember 31, 2026
Study endsJune 30, 2027
Registry record updatedApril 9, 2026
Trial IDNCT07521111 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) admitted to the ICU who are expected to require enteral nutrition for more than 7 days and who (or whose legal representatives) can provide informed consent are ideal candidates.

Probably not a fit

Patients with recent major gastrointestinal surgery, contraindications to abdominal POCUS, severe baseline gastrointestinal disease, severe peripheral vascular or valvular heart disease, or who are pregnant or lactating are excluded and would not benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational cohort at Ruijin Hospital where researchers will perform bedside point-of-care ultrasound on ICU patients at admission and on Day 1, Day 4, and Day 7 of enteral nutrition. Ultrasound measurements will include vessel diameters, time-averaged maximum velocity, calculated blood flow, and VExUS scores for the celiac artery, superior mesenteric artery, portal vein, hepatic vein, and inferior vena cava. The team will use these hemodynamic parameters, alongside routine clinical indicators, to build and compare three predictive models using machine learning methods. The goal is to determine whether adding blood flow data improves early prediction of enteral nutrition intolerance compared with clinical data alone.

Why it matters

Potential benefit: If successful, the approach could allow clinicians to identify patients at high risk of feeding intolerance earlier and personalize nutrition plans to reduce interruptions and complications.

How similar studies have gone: Prior research links gut perfusion and hemodynamics to gastrointestinal dysfunction and POCUS is used for bedside hemodynamic assessment, but using serial GI blood flow measurements plus machine learning to predict enteral nutrition intolerance is largely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 years old.
* Expected duration of enteral nutrition support \> 7 days.
* Patients or their legal representatives sign the informed consent form.

Exclusion Criteria:

* History of major gastrointestinal surgery such as subtotal gastrectomy and gastrointestinal anastomosis.
* Contraindications to abdominal point-of-care ultrasound (POCUS) examination (e.g., recent large-area abdominal burns, dressings blocking movement, open abdomen).
* Presence of severe gastrointestinal diseases such as gastroparesis, intestinal obstruction, digestive tract perforation, and gastrointestinal bleeding upon admission.
* Presence of severe peripheral vascular disease or valvular heart disease.
* Pregnant or lactating women.

Where it's running

  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.